Reference
EVUSHELD (tixagevimab and cilgavimab for injection) - Risk of Prophylaxis or Treatment Failure due to Antiviral Resistance Internet Document : 1 Nov 2022. Available from: URL: https://recalls-rappels.canada.ca/en/alert-recall/evusheld-tixagevimab-and-cilgavimab-injection-risk-prophylaxis-or-treatment-failure
Rights and permissions
About this article
Cite this article
Risk of EVUSHELD treatment failure due to antiviral resistance. Reactions Weekly 1931, 6 (2022). https://doi.org/10.1007/s40278-022-26803-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-022-26803-1